Paul Dorinsky

6PUBLICATIONS
26CO-AUTHORS
Behavioural epidemiologyPrimary health careHuman biophysicsPredictive and prognostic markersPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 13, 2022
Benefits of Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate on COPD Exacerbations, Lung Function, Symptoms, and Quality of Life Across Blood Eosinophil Ranges: A Post-Hoc Analysis of Data from ETHOS.

Mona Bafadhel, Klaus F Rabe, Fernando J Martinez

|Aug 20, 2021
CONQUEST Quality Standards: For the Collaboration on Quality Improvement Initiative for Achieving Excellence in Standards of COPD Care.

Rachel Pullen, Marc Miravitlles, Anita Sharma

|Feb 05, 2021
Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Improves Exacerbation Outcomes in Patients with COPD without a Recent Exacerbation History: A Subgroup Analysis of KRONOS.

Fernando J Martinez, Gary T Ferguson, Eric Bourne

|Aug 22, 2020
The Long-Term Burden of COPD Exacerbations During Maintenance Therapy and Lung Function Decline.

Marjan Kerkhof, Jaco Voorham, Paul Dorinsky

|Jan 11, 2020
Long-Term Safety and Efficacy of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD.

Masakazu Ichinose, Yasushi Fukushima, Yoshikazu Inoue

|Jan 11, 2020
Efficacy and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD: A Subgroup Analysis of the KRONOS Study.

Masakazu Ichinose, Yasushi Fukushima, Yoshikazu Inoue

Pageof 1

Frequent Collaborators

3 joint publications

Fernando Martinez

2 joint publications

Yasushi Fukushima

2 joint publications

Yoshikazu Inoue

2 joint publications

Nobuya Hayashi